[go: up one dir, main page]

PT797987E - Preparacao granular de libertacao controlada e processo para a sua preparacao - Google Patents

Preparacao granular de libertacao controlada e processo para a sua preparacao

Info

Publication number
PT797987E
PT797987E PT95940461T PT95940461T PT797987E PT 797987 E PT797987 E PT 797987E PT 95940461 T PT95940461 T PT 95940461T PT 95940461 T PT95940461 T PT 95940461T PT 797987 E PT797987 E PT 797987E
Authority
PT
Portugal
Prior art keywords
preparation
sustained
granular preparations
plasticizer
granules
Prior art date
Application number
PT95940461T
Other languages
English (en)
Inventor
Hiroaki Nakagami
Masazumi Kojima
Shinji Sagasaki
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of PT797987E publication Critical patent/PT797987E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT95940461T 1994-12-19 1995-12-18 Preparacao granular de libertacao controlada e processo para a sua preparacao PT797987E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31441494 1994-12-19

Publications (1)

Publication Number Publication Date
PT797987E true PT797987E (pt) 2004-02-27

Family

ID=18053063

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95940461T PT797987E (pt) 1994-12-19 1995-12-18 Preparacao granular de libertacao controlada e processo para a sua preparacao

Country Status (14)

Country Link
US (2) US5858411A (pt)
EP (1) EP0797987B1 (pt)
JP (1) JP3893439B2 (pt)
KR (1) KR100424931B1 (pt)
CN (1) CN1093758C (pt)
AT (1) ATE251896T1 (pt)
DE (1) DE69531957T2 (pt)
DK (1) DK0797987T3 (pt)
ES (1) ES2210321T3 (pt)
FI (1) FI119720B (pt)
NO (1) NO320356B1 (pt)
PT (1) PT797987E (pt)
TW (1) TW406022B (pt)
WO (1) WO1996019200A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
DK0901786T3 (da) 1997-08-11 2007-10-08 Pfizer Prod Inc Faste farmaceutiske dispersioner med foröget biotilgængelighed
US6632455B2 (en) * 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
CN1165296C (zh) * 1998-09-30 2004-09-08 Basf公司 水溶性或水可分散性含聚醚聚合物作为在药物给药形式中的包衣剂、粘合剂和/或成膜赋形剂的应用
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US6316462B1 (en) * 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
WO2006023001A1 (en) * 2004-07-30 2006-03-02 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20060275365A1 (en) * 2005-06-07 2006-12-07 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl) [4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20070059359A1 (en) * 2005-06-07 2007-03-15 Thomas Backensfeld Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
CA2612292C (en) 2005-06-20 2013-09-03 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US9034373B2 (en) * 2006-03-16 2015-05-19 Euro-Celtique S.A. Pharmaceutical spheroids
KR101697773B1 (ko) * 2008-03-10 2017-01-18 유로드러그 레버러토리즈 비. 브이. 독소필린을 포함하는 변형 방출 조성물
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
US20110184060A1 (en) * 2010-01-22 2011-07-28 Xenoport, Inc. Oral dosage forms having a high loading of a tranexamic acid prodrug
WO2011102505A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
KR102286952B1 (ko) * 2013-12-31 2021-08-09 롯데정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
CN109414441A (zh) 2016-06-27 2019-03-01 艾其林医药公司 治疗医学障碍的喹唑啉和吲哚化合物
CA3053818A1 (en) 2017-03-01 2018-09-07 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4329451A (en) * 1980-11-03 1982-05-11 The Dow Chemical Company Preparing an aqueous dispersion of colloidal size particles of a water-insoluble polysaccharide derivative
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
EP0421582A1 (en) * 1989-10-03 1991-04-10 Warner-Lambert Company Chewable spray dried spheroidal microcapsules and polymer coated microcapsules and method for preparing same
JPH03232814A (ja) * 1990-02-08 1991-10-16 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
JP2915590B2 (ja) * 1991-02-15 1999-07-05 第一製薬株式会社 マスクされた粒状物
WO1992018106A1 (en) * 1991-04-16 1992-10-29 Nippon Shinyaku Co., Ltd. Method of manufacturing solid dispersion
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten

Also Published As

Publication number Publication date
ATE251896T1 (de) 2003-11-15
NO320356B1 (no) 2005-11-28
EP0797987A1 (en) 1997-10-01
US6030644A (en) 2000-02-29
FI119720B (fi) 2009-02-27
JP3893439B2 (ja) 2007-03-14
TW406022B (en) 2000-09-21
EP0797987A4 (en) 1998-09-09
ES2210321T3 (es) 2004-07-01
US5858411A (en) 1999-01-12
CN1093758C (zh) 2002-11-06
FI972622A0 (fi) 1997-06-18
FI972622A (fi) 1997-06-18
CN1170357A (zh) 1998-01-14
NO972814D0 (no) 1997-06-18
KR100424931B1 (ko) 2004-07-05
DE69531957T2 (de) 2004-08-12
EP0797987B1 (en) 2003-10-15
NO972814L (no) 1997-08-18
WO1996019200A1 (fr) 1996-06-27
DE69531957D1 (de) 2003-11-20
DK0797987T3 (da) 2004-02-16

Similar Documents

Publication Publication Date Title
PT797987E (pt) Preparacao granular de libertacao controlada e processo para a sua preparacao
MY109813A (en) Process of preparing large dimension emulsion polymer particles, polymer product and uses thereof
FR2627773B1 (fr) Particules fines de polyorganosilsesquioxane et procede de production de ces particules
NO944473D0 (no) Sammensetninger med vedvarende frigjöring og fremgangsmåte for fremstilling av farmasöytiske sammensetninger
HUT54861A (en) Process for producing dosage units, dosage units in pressed form and their application
DE59305700D1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
DE68916048D1 (de) Verfahren zur Herstellung von monodispersen Polymerteilchen mit erhöhter Teilchengrösse.
MX164018B (es) Metodo para tratar substratos
TW270085B (pt)
HUT61196A (en) Process for producing pharmaceutical composition which may be dropped in the eye
DE69625813D1 (de) Pranlukast enthaltende granula, verfahren zur herstellung der granula und verfahren zur verminderung des zusammenbackens von pranlukast
PT91852A (pt) Processo para a preparacao de produtos contendo psyllium
EP0606930A3 (en) Process for preparation of polymer particles, process for preparation of toner particles and particles prepared according to these processes.
DE69026546D1 (de) Glimmerartige, vernetzbare, oberflächenmodifizierte Teilchen und Beschichtungszusammensetzungen, die diese enthalten
ATE142904T1 (de) Reduzierung des fomaldehydegehalts in mikrokapsel formulierung
EP0411461A3 (en) Hydrophilic polycarbodiimide polymer,pulp-like material consisting of said hydrophilic polycarbodiimide polymer, and process for producing said polymer or said material
HU9401412D0 (en) Process for producing dry- processed particles, the produced dry-processed paricles, and pharmaceutical compositions containing them
CA2207334A1 (en) Sustained-release granular preparations and production process thereof
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
EP0410554A3 (en) 14,17-alpha-ethano- and ethano-estratrienes, process for their production and their use in the production of pharmaceuticals
ATE102025T1 (de) Nichtfestes augenarzneimittel und verfahren zur herstellung dieses arzneimittels.
HUT60509A (en) Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
ZA200006695B (en) Granulator organosilane preparation, process for the production thereof and use thereof.